399 related articles for article (PubMed ID: 26806063)
21. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
22. Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
BMC Neurol; 2020 Aug; 20(1):308. PubMed ID: 32814565
[TBL] [Abstract][Full Text] [Related]
23. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
24. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.
Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J
J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353
[TBL] [Abstract][Full Text] [Related]
25.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
26. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
27. Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.
Zhang Q; Wang R; Liu Y; Zhang Y; Wang S; Cao Y; Zhao Y; Liu X; Wang J; Deng X; Gao F; Yang Z; Zhao M; Ge P; Ma Y; Zhao J; Zhang D
World Neurosurg; 2016 Dec; 96():474-482. PubMed ID: 27647029
[TBL] [Abstract][Full Text] [Related]
28. Association of
Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J
Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.
Kamimura T; Okazaki S; Morimoto T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Yoshimoto T; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Maruyama H; Koizumi A; Ihara M
Stroke; 2019 Jun; 50(6):1561-1563. PubMed ID: 31060437
[TBL] [Abstract][Full Text] [Related]
30. Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
Okazaki S; Morimoto T; Kamatani Y; Kamimura T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Washida K; Saito S; Takahashi A; Hirata M; Matsuda K; Mochizuki H; Chong M; Paré G; O'Donnell M; Ago T; Hata J; Ninomiya T; Dichgans M; Debette S; Kubo M; Koizumi A; Ihara M
Circulation; 2019 Jan; 139(2):295-298. PubMed ID: 30615506
[No Abstract] [Full Text] [Related]
31. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
[TBL] [Abstract][Full Text] [Related]
32. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
[TBL] [Abstract][Full Text] [Related]
35. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
36. Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.
Chen J; Zheng H; Wu X; Niu X; Dai Y; Zhou Z; Ye F
J Stroke Cerebrovasc Dis; 2024 Mar; 33(3):107581. PubMed ID: 38224792
[TBL] [Abstract][Full Text] [Related]
37. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
